Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation

Jung Hyun Park, Yeonjoo Jung, Tai Young Kim, Sang Gyun Kim, Hyun Soon Jong, Jung Weon Lee, Dae Kee Kim, Jong Soo Lee, Noe Kyeong Kim, Tae You Kim, Yung Jue Bang

Research output: Contribution to journalArticlepeer-review

142 Scopus citations


We have developed previously a class of synthetic hybrid histone deacetylase (HDAC) inhibitors, which were built from hydroxamic acid of trichostatin A and pyridyl ring of MS-275. In this study we evaluated the antitumor effects of these novel hybrid synthetic HDAC inhibitors, SK-7041 and SK-7068, on human cancer cells. Both SK-7041 and SK-7068 effectively inhibited cellular HDAC activity at nanomolar concentrations and induced the time-dependent hyperacetylation of histones H3 and H4. These HDAC inhibitors preferentially inhibited the enzymatic activities of HDAC1 and HDAC2, as compared with the other HDAC isotypes, indicating that class I HDAC is the major target of SK-7041 and SK-7068. We found that these compounds exhibited potent antiproliferative activity against various human cancer cells in vitro. Growth inhibition effect of SK-7041 and SK-7068 was related with the induction of aberrant mitosis and apoptosis in human gastric cancer cells. Both compounds induced the accumulation of cells at mitosis after 6 h of treatment, which was demonstrated by accumulation of tetraploid cells, lack of G2 cyclin/cyclin-dependent kinase inactivation, and higher mitotic index. After 12 h of treatment, apoptotic cells were increased through mitochondrial and caspase-mediated pathway. Finally, in vivo experiment showed that SK-7041 or SK-7068 was found to reduce the growth of implanted human tumors in nude mice. Therefore, based on isotype specificity and antitumor activity, SK-7041 and SK-7068 HDAC inhibitors are expected to be promising anticancer therapeutic agents and need additional clinical development.

Original languageEnglish
Pages (from-to)5271-5281
Number of pages11
JournalClinical Cancer Research
Issue number15
StatePublished - 1 Aug 2004


Dive into the research topics of 'Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation'. Together they form a unique fingerprint.

Cite this